Vyvanse Capsule
Pricing Report NDC 59417-102-10

Current NADAC: $12.34861 per EA · Effective Aug 19, 2026 · Est. package price $1,234.86 (100 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The current wholesale acquisition cost for Vyvanse (NDC 59417-102-10) is $12.34861 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 19, 2026.

As a a human prescription drug provided by Takeda Pharmaceuticals America, Inc., this medication is distributed in a 100 CAPSULE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$12.34861
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Aug 19, 2026
Billable Units
100 EA
Estimated Package Price
$1,234.86
Data Status
As of Sep 09, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
59417-102-10
Description
100 CAPSULE in 1 BOTTLE
Generic Benchmark
The generic equivalent rate is $2.59686 (Effective: Aug 19, 2026)
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jul 2013, the NADAC wholesale price for (NDC ) has moved within a range of $6.00828 to $12.39465 per EA. Over this 13 years and 1 month period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$6.0083 - $12.3947
Market Volatility
106.29% Variance
Latest Trend
No Change

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $12.34861 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 22, 2026 $12.34895 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 17, 2026 $12.35076 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2026 $12.35186 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Apr 22, 2026 $12.34980 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Mar 18, 2026 $12.35057 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Feb 18, 2026 $12.35860 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 21, 2026 $12.34975 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Dec 17, 2025 $12.34928 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Nov 19, 2025 $12.35497 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 22, 2025 $12.35729 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Sep 17, 2025 $12.36858 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026